We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$16B
AUM Growth
-$1.4B
Cap. Flow
-$442M
Cap. Flow %
-2.77%
Top 10 Hldgs %
29.19%
Holding
720
New
51
Increased
199
Reduced
358
Closed
49

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$121M
2
ONC
BeOne Medicines Ltd
ONC
+$66.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$56.6M
4
WELL icon
Welltower
WELL
+$48.8M
5
CRDO icon
Credo Technology Group
CRDO
+$45.3M

Top Sells

Rank Stock Value
1
ALTR
Altair Engineering Inc
ALTR
+$67M
2
UNH icon
UnitedHealth
UNH
+$44.7M
3
APH icon
Amphenol
APH
+$43.9M
4
BDX icon
Becton Dickinson
BDX
+$36.4M
5
LLY icon
Eli Lilly
LLY
+$36.1M

Sector Composition

Rank Sector Weight
1 Technology 31.51%
2 Healthcare 25.4%
3 Financials 11.6%
4 Consumer Discretionary 7.99%
5 Industrials 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWLO icon
176
Twilio
TWLO
$28.2B
$17.1M 0.11%
174,572
+2,655
+2% +$315K
CCK icon
177
Crown Holdings
CCK
$13B
$16.9M 0.11%
189,452
+17,715
+10% +$1.55M
JXN icon
178
Jackson Financial
JXN
$8.56B
$16.7M 0.1%
198,900
-16,818
-8% -$1.49M
GWW icon
179
W.W. Grainger
GWW
$65.3B
$16.6M 0.1%
16,816
-2,721
-14% -$2.81M
ORCL icon
180
Oracle
ORCL
$341B
$16.6M 0.1%
118,388
+4,415
+4% +$719K
CRNX icon
181
Crinetics Pharmaceuticals
CRNX
$8.87B
$16.4M 0.1%
+488,911
New +$18.3M
ARQT icon
182
Arcutis Biotherapeutics
ARQT
$3.49B
$16.2M 0.1%
1,035,576
-6,568
-0.6% -$92.5K
SMMT icon
183
Summit Therapeutics
SMMT
$9.89B
$16.2M 0.1%
838,518
-4,033
-0.5% -$80.9K
INTU icon
184
Intuit
INTU
$88.7B
$16M 0.1%
26,036
-15,182
-37% -$9.12M
SRRK icon
185
Scholar Rock
SRRK
$5.84B
$16M 0.1%
496,756
-85,598
-15% -$3.29M
CVS icon
186
CVS Health
CVS
$139B
$15.9M 0.1%
234,091
+123,891
+112% +$7.41M
BRKR icon
187
Bruker
BRKR
$9.73B
$15.8M 0.1%
379,027
+194,081
+105% +$10.1M
C icon
188
Citigroup
C
$217B
$15.5M 0.1%
218,775
+17,915
+9% +$1.37M
EXAS
189
DELISTED
Exact Sciences
EXAS
$15.5M 0.1%
356,975
-4,688
-1% -$237K
PAYC icon
190
Paycom
PAYC
$7.87B
$15.4M 0.1%
70,704
+13,709
+24% +$2.89M
RYTM icon
191
Rhythm Pharmaceuticals
RYTM
$7.39B
$15.4M 0.1%
291,469
-40,923
-12% -$2.27M
IDYA icon
192
IDEAYA Biosciences
IDYA
$3.48B
$15.4M 0.1%
938,177
-133,648
-12% -$2.85M
XENE icon
193
Xenon Pharmaceuticals
XENE
$6.26B
$15.3M 0.1%
454,650
-37,531
-8% -$1.43M
HLT icon
194
Hilton Worldwide
HLT
$72B
$15.1M 0.09%
66,430
-23,954
-27% -$5.97M
T icon
195
AT&T
T
$168B
$15M 0.09%
530,679
-25,570
-5% -$643K
USB icon
196
US Bancorp
USB
$99.4B
$15M 0.09%
354,385
+196,548
+125% +$9.07M
WPC icon
197
W.P. Carey
WPC
$17.1B
$14.9M 0.09%
+236,875
New +$14M
DFS
198
DELISTED
Discover Financial Services
DFS
$14.7M 0.09%
85,995
-3,860
-4% -$706K
ROP icon
199
Roper Technologies
ROP
$39.6B
$14.7M 0.09%
24,877
-5,285
-18% -$2.97M
GIS icon
200
General Mills
GIS
$20.4B
$14.4M 0.09%
241,643
+2,577
+1% +$155K
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2025 Portfolio in Review

As of Q1 2025, Candriam SCA held 720 positions worth $16B, down 8.1% from $17.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Candriam SCA's Q1 2025 filing shows 51 new, 199 increased, 358 reduced and 49 closed positions. Its largest new stake was BeOne Medicines Ltd: 285,893 shares worth $77.8M. The largest sale was Altair Engineering Inc, an estimated $67M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2025 buy was BeOne Medicines Ltd: 285,893 shares worth $77.8M.
  • Candriam SCA added most to Meta Platforms (Facebook) in Q1 2025, an estimated $121M increase.
  • Candriam SCA's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $44.7M.
  • Candriam SCA fully exited Altair Engineering Inc in Q1 2025, selling an estimated $67M.
  • Candriam SCA's ten largest holdings make up 29% of its $16B portfolio in Q1 2025.
  • Candriam SCA opened 51 new positions and closed 49 in Q1 2025.
  • Candriam SCA's portfolio value fell 8.1% quarter-over-quarter to $16B.

Based on Candriam SCA's 13F filing for Q1 2025, filed 14 May 2025.